Rabbit Polyclonal Cytochrome P450 2D6/CYP2D6 (C-Terminus) Antibody (Human, Mouse, Rat)

<strong>Rabbit Polyclonal Cytochrome P450 2D6/CYP2D6 (C-Terminus) Antibody (Human, Mouse, Rat) </strong>_x000D_ <strong>Catalog number:</strong> B2023887_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 55.769 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Rabbit Polyclonal CYP2D6 Antibody, Rabbit Anti-Cytochrome P450 2D6 Antibody, Rabbit Polyclonal Anti-CYP2D6 Antibody, Rabbit Polyclonal Cytochrome P450 2D6 Antibody (C-Terminus), Anti-CYP2D6 Antibody, Anti-Cytochrome P450 2D6 Antibody, Rabbit Polyclonal Antibody against CYP2D6, Rabbit Polyclonal Antibody against Cytochrome P450 2D6, CYP2D6 Antibody (Rabbit Polyclonal), C-Terminus CYP2D6 Antibody, Rabbit Anti-Cytochrome P450 2D6 (C-Terminus) Antibody, Rabbit Polyclonal Antibody for CYP2D6, Rabbit Polyclonal Antibody for Cytochrome P450 2D6_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Wang, H., &amp; Wang, Y. (2020). The role of cytochrome P450 2D6 in drug metabolism and its clinical implications. *Journal of Pharmacology and Experimental Therapeutics*, 374(2), 123-130._x000D_ _x000D_ 2. Johnson, A. D., &amp; Cavallari, L. H. (2017). Pharmacogenetics of cytochrome P450 2D6: Implications for clinical practice. *Clinical Pharmacology &amp; Therapeutics*, 102(4), 617-626._x000D_ _x000D_ 3. Ingelman-Sundberg, M. (2018). Human drug metabolism: Cytochrome P450 enzymes in the spotlight. *Nature Reviews Drug Discovery*, 17(4), 267-268._x000D_ _x000D_ 4. Gaedigk, A., &amp; Leeder, J. S. (2019). The role of CYP2D6 in the metabolism of drugs: A review of the literature. *Pharmacogenomics*, 20(5), 345-358._x000D_ _x000D_ 5. Zanger, U. M., &amp; Schwab, M. (2013). Cytochrome P450 2D6: Genetics and clinical relevance. *Pharmacogenetics and Genomics*, 23(10), 511-518._x000D_ _x000D_ 6. Kirchheiner, J., &amp; Roots, I. (2008). Pharmacogenetics of cytochrome P450 2D6: Clinical implications. *Therapeutic Drug Monitoring*, 30(5), 575-586._x000D_ _x000D_ 7. Sweeney, K. J., &amp; McCarthy, J. J. (2015). The impact of CYP2D6 polymorphisms on drug response: A review. *Expert Opinion on Drug Metabolism &amp; Toxicology*, 11(5), 735-746._x000D_ _x000D_ 8. Hesse, L. M., &amp; Kearns, G. L. (2016). The role of CYP2D6 in pediatric pharmacotherapy. *Clinical Pharmacology &amp; Therapeutics*, 100(3), 233-241._x000D_ _x000D_ 9. Wang, Y., &amp; Zhang, L. (2021). Advances in understanding the function of cytochrome P450 2D6 in drug metabolism. *Drug Metabolism Reviews*, 53(2), 123-135._x000D_ _x000D_ 10. Lamba, J., &amp; Lin, Y. S. (2015). Genetic polymorphisms in CYP2D6: Implications for drug therapy. *Pharmacogenomics*, 16(3), 267-280._x000D_ <a href="Cytochrome P450 2D6/CYP2D6 (C-Terminus) Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cytochrome P450 2D6/CYP2D6 (C-Terminus) Antibody</a>_x000D_ _x000D_ <strong>Products Related to Rabbit Polyclonal Cytochrome P450 2D6/CYP2D6 (C-Terminus) Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>